A second phase study for the cancer pain: Drug Rotation from Oral Opioid to Daily type Transdermal Fentanyl tape.

A second phase study for the cancer pain: Drug Rotation from Oral Opioid to Daily type Transdermal Fentanyl tape. - PROOF study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007863

Enrollment

Registered

2012-05-01

Start date

2012-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer pain

Interventions

from oral opioid to transdermal fentanyl tape

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with moderate-severe cancer-related pain 2. In-patients and out-patients 3. Patients without a problem clear in cognitive ability 4. Age: = or >20 5. Patients who has received the notice to cancer 6. Patients considered as appropriate for the treatment of opioid by investigators 7. Patients who are provided informed, written consent for participation

Exclusion criteria

Exclusion criteria: 1. Patients with serious hepatic, renal, heart or respiratory dysfunctions 2. Patients with medical history of psychiatry disease 3. Pregnant or nursing patients and patients who may be pregnant 4. Patients with disturbed consciousness 5. Contraindication to opioid 6. Patients who has received narcotic antagonist analgesic 7. Patients who is evaluated as in appropriate for this study by investigator

Design outcomes

Primary

Measure	Time frame
the rate of pain reduction	—

Countries

Japan

Contacts

Public ContactKazuhisa Katayama

ISESAKI MUNICIPAL HOSPITAL Department of Surgery

kazukatayama827@gmail.com0270-25-5022

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026